Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular DiseaseMichelle L. O’Donoghue, Marc S. Sabatine, Elmer Stout et al.|New England Journal of Medicine|2022Cited by 513
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trialJean‐Claude Tardif, Guy Boivin, Nadia Bouabdallaoui et al.|The Lancet Respiratory Medicine|2021Cited by 271
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseasesYehuda Handelsman, John Wilding, John E. Anderson et al.|Metabolism|2024Cited by 76